Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC16H19ClN4O |
InChIKeyQHKXDHJQHJXHGV-UHFFFAOYSA-N |
CAS Registry2180931-49-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | BR | 28 Jun 2016 |